Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Radio Review: You and Yours - How IVF Became Big Business

20 May 2013

By Jenny Dunlop

Senior Infertility Counsellor

Appeared in BioNews 705

You and Yours: How IVF Became Big Business

BBC Radio 4, Thursday 2 May 2013

Presented by Kate Silverton

'You and Yours: How IVF Became Big Business', BBC Radio 4, Thursday 2 May 2013


Kate Silverton is well known for reading the BBC news, so I was interested to listen to her short report on how IVF has become such a big business. With the UK spending £500 million on IVF every year, she wanted to know why it should cost so much. Coming to this with personal knowledge of having had four IVF attempts but eventually conceiving naturally, she was concerned with how IVF can drastically change people's lives and the lack of transparency about the costs associated with it.

Silverton covered the issue of the costs of private treatment with Mr Hossam Abdalla, the clinical director of the Lister Fertility Clinic, where she had received fertility treatment. Although he said that they tried to be transparent, it seemed that costs could still be confusing for patients. Silverton then spoke to a patient undergoing IVF treatment about the need to get a loan to cover the costs, and how this can be stressful as the success of treatment isn't guaranteed.

Clare Lewis-Jones, from Infertility Network UK, explained that there was still a postcode lottery, with only 25 percent of people able to access the three cycles from the NHS that the National Institute for Health and Care Excellence (NICE) had recommended. She made a valid comment that with the change from primary care trusts (PCTs) to clinical commissioning groups (CCGs), there was a worry about the future and funding of IVF.

Other ways of helping with costs of treatment were also looked at, such as egg sharing. Although egg sharing has helped many couples achieve pregnancies, as Clare Lewis-Jones pointed out, there is still a considerable residual worry about why women come forward to share their eggs. Are they doing it just to access IVF? For the donors who don’t get pregnant, what are the implications for the future?

Professor Geeta Nargund spoke about another, cheaper option, natural IVF, where the one egg released monthly is collected and fertilised. Without the need for expensive fertility drugs and cycle monitoring, it is much cheaper than conventional IVF, but as its effectiveness is currently unknown, NICE has not recommended it as an option for NHS patients.

The idea of capping costs was discussed with Professor Nargund, who was in favour of it, as it would reduce confusion for patients unsure whether to receive treatment privately or on the NHS. However, Mr Abdalla felt it would not work, as it would require standards to be consistent across the UK. Clare Lewis-Jones felt that people should stop worrying about the private sector and concentrate on sorting out the NHS treatments recommended by NICE.

Overall, it was too short a programme to do justice to this serious issue, at only 12 minutes long. It came over that many patients couldn’t understand why it should be so expensive. Kate Silverton ended the report saying she didn’t understand why the costs couldn't be capped. I think that people in this business also ask these questions themselves: why some clinics charge more than others, and how the NHS clinics can charge PCTs/CCGs less than some private clinics charge their private patients. Many of these important questions still go unanswered.

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

10 June 2013 - by George Frodsham 
We live in a world in which the demand for progress and solutions is at fever pitch. But by overlooking projects that may not yield immediate benefits, or ignoring the fundamental science that can unexpectedly make new discoveries, we risk missing out on invaluable new understandings, technologies and treatments...

22 April 2013 - by Antony Blackburn-Starza 
The Progress Educational Trust's debate, 'NICE Try… But is anyone listening?', considered the impact of the radical structural changes to the NHS on the state provision of IVF. At least two central critical themes emerged from the debate: a critique of method and a critique of measure...
25 February 2013 - by Mark Johnson 
On 20 February 2013, the National Institute for Health and Clinical Excellence published its new guideline on the assessment and treatment of couples with fertility problems...
10 December 2012 - by Ari Haque 
A couple who was refused fertility treatment on the NHS for being 'too old' has said it intends to challenge the decision in the courts, arguing that the decision amounts to age discrimination....
17 September 2012 - by Peter Thompson 
It's a busy week for the Human Fertilisation and Embryology Authority (HFEA). As we launch our government-commissioned public consultation on mitochondria replacement, we are in the midst of a public debate about who should regulate IVF and embryo research. We will publish our response to the Government's consultation on the HFEA's future later this week. This comment piece gives a taste of what we will be saying....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation